首页> 美国卫生研究院文献>Annals of Surgery >An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes B and C rectal carcinoma. A report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project.
【2h】

An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes B and C rectal carcinoma. A report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project.

机译:杜克斯B和C直肠癌的腹部手术和保留括约肌切除术后生存和治疗失败的分析。 NSABP临床试验报告。国家外科手术辅助性乳房和肠项目。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abdominoperineal resections for rectal carcinoma are being performed with decreasing frequency in favor of sphincter-saving resections. It remains, however, to be unequivocally demonstrated that sphincter preservation has not resulted in compromised local disease control, disease-free survival, and survival. Accordingly, it is the specific aim of this endeavor to compare local recurrence, disease-free survival, and survival in patients with Dukes' B and C rectal cancer undergoing curative abdominoperineal resection or sphincter-saving resection. For the purpose of this study, 232 patients undergoing abdominoperineal resection and 181 subjected to sphincter-saving resections were available for analysis from an NSABP randomized prospective clinical trial designed to ascertain the efficacy of adjuvant therapy in rectal carcinoma (protocol R-01). The mean time on study was 48 months. Analyses were carried out comparing the two operations according to Dukes' class, the number of positive nodes, and tumor size. The only significant differences in disease-free survival and survival were observed for the cohort characterized by greater than 4 positive nodes and were in favor of patients treated with sphincter-saving resections. A patient undergoing sphincter-saving resection was 0.62 times as likely to sustain a treatment failure as a similar patient undergoing abdominoperineal resection (p = 0.07) and 0.49 times as likely to die (p = 0.02). The inability to demonstrate an attenuated disease-free survival and survival for patients treated with sphincter-saving resection was in spite of an increased incidence of local recurrence (anastomotic and pelvic) observed for the latter operation when compared to abdominoperineal resection (13% vs. 5%). A similar analysis evaluating the length of margins of resection in patients undergoing sphincter-preserving operations indicated that treatment failure and survival were not significantly different in patients whose distal resection margins were less than 2 cm, 2-2.9 cm, or greater than or equal to 3 cm. If any trend was observed, it appeared that patients with smaller resection margins had a slightly prolonged survival (p = 0.10). This observation was present in spite of the fact that local recurrence as a first site of treatment failure was greater in the group with less than 2 cm that it was in the greater than or equal to 3 cm category, 22% versus 12%. This increased local recurrence rate in the population with smaller margins was not translated into an in crease in overall treatment failure and had absolutely no influence on survival. It is suggested that local recurrence serves as a marker of distant disease.(ABSTRACT TRUNCATED AT 400 WORDS)
机译:直肠癌的腹部手术切除术的频率降低,有利于节省括约肌的切除术。但是,仍然有待明确证明,括约肌保存并未导致局部疾病控制,无病生存和生存受到损害。因此,这项工作的具体目的是比较接受根治性腹部手术切除或保留括约肌切除的Dukes'B和C直肠癌患者的局部复发率,无病生存率和生存率。出于本研究的目的,可从一项旨在确定直肠癌辅助治疗疗效的NSABP随机前瞻性临床试验中对232例行腹腔手术切除的患者和181例行括约肌切除术的患者进行分析(协议R-01)。平均研究时间为48个月。根据Dukes的分类,阳性淋巴结数目和肿瘤大小,对两种手术进行了比较分析。对于以多于四个阳性淋巴结为特征的队列,观察到无病生存率和生存率的唯一显着差异,这有利于采用保留括约肌切除术的患者。保留括约肌切除术的患者维持治疗失败的可能性是接受腹腔手术切除的类似患者的0.62倍(p = 0.07),而死亡的可能性为0.49倍(p = 0.02)。尽管与腹部手术切除相比,后者手术中局部复发(解剖和骨盆)的发生率有所增加,但仍无法证明无括约肌切除术的无病生存期和存活率均降低(13%vs. 13%)。 5%)。一项类似的评估保留括约肌手术的患者切除边缘的长度的分析表明,对于远端切除边缘小于2 cm,2-2.9 cm或大于或等于2的患者,治疗失败和生存率无显着差异3厘米如果观察到任何趋势,则表明切缘较小的患者生存期略有延长(p = 0.10)。尽管存在以下观察:尽管在小于2 cm的组中局部复发是治疗失败的第一部位,但在大于或等于3 cm的组中,局部复发更大,分别为22%和12%。在边缘较小的人群中这种局部复发率的提高并未转化为总体治疗失败的增加,并且绝对不会影响生存率。建议将局部复发作为远处疾病的标志。(摘要截短为400字)

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号